Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study

Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study

Bernardo Dell&rsquo;Osso, Chiara Arici, Cristina Dobrea, Giulia Camuri, Beatrice Benatti, A Carlo AltamuraUniversity of Milan, Department of Psychiatry, Fondazione IRCSS Ca&rsquo; Granda, Ospedale Maggiore Policlinico, Milano, ItalyBackground: Escitalopram is a selective serotonin re...

Full description

Bibliographic Details
Main Authors:	Dell&#39;Osso B, Arici C, Dobrea C, Camuri G, Benatti B, Altamura AC
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-02-01
Series:	Neuropsychiatric Disease and Treatment
Online Access:	http://www.dovepress.com/escitalopram-tolerability-as-mono--versus-augmentative-therapy-in-pati-a12165

Similar Items

Quetiapine augmented with escitalopram in treating delusional parasitosis
by: Hung Chiang, et al.
Published: (2019-01-01)

Escitalopram versus other antidepressive agents for depression.
by: Cipriani, A, et al.
Published: (2009)

Behavioral restriction, lorazepam, and escitalopram uniquely influence the expression of naturalistic stereotypy in deer mice: perspectives on anxiety- and compulsive-like behavior
by: Johann T. Burke, et al.
Published: (2022-12-01)

Il desiderio e l'ossessione del desiderio
by: Alfredo Carlo Altamura, et al.
Published: (2014-07-01)

Perospirone augmentation of escitalopram in the treatment of an adolescent sophophobia (fear of learning) patient
by: Kensuke Miyazaki
Published: (2022-09-01)

Antidepressant-induced sexual dysfunction: A naturalistic study comparing sexual dysfunction among patients taking escitalopram, desvenlafaxine, and mirtazapine
by: Raj Kiran Donthu, et al.
Published: (2021-01-01)

Effects of psilocybin versus escitalopram on rumination and thought suppression in depression
by: Tommaso Barba, et al.
Published: (2022-09-01)

Escitalopram in patients with psoriasis
by: M. Artemieva, et al.
Published: (2021-04-01)

A Study about Escitalopram Versus Citalopram in the Treatment of Depressive Disorders
by: Jasim M. Shindi, et al.
Published: (2015-08-01)

Methylphenidate augmentation of escitalopram to enhance adherence to antidepressant treatment: a pilot randomized controlled trial
by: Martin P. Paulus, et al.
Published: (2021-11-01)

Escitalopram-induced rabbit syndrome
by: Nitish Batra, et al.
Published: (2023-01-01)

Severe hyponatremia associated with escitalopram
by: Gautam Rawal, et al.
Published: (2017-01-01)

Escitalopram Induced Drug Eruption
by: Bhatia M S
Published: (2004-01-01)

Short-term escitalopram treatment and hippocampal volume.
by: Godlewska, B, et al.
Published: (2014)

Safety of escitalopram in pregnancy: a case series
by: Bellantuono C, et al.
Published: (2013-09-01)

An Open-Label Rater-Blinded Randomized Trial of Vilazodone versus Escitalopram in Major Depression
by: Pattath Narayanan Suresh Kumar, et al.
Published: (2023-01-01)

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
by: Kishi T, et al.
Published: (2017-01-01)

Mydriasis caused by ESCITALOPRAM: Case report
by: N. Bouattour, et al.
Published: (2022-06-01)

Female sexual dysfunction and Escitalopram antidepressant
by: Ali Mahran, et al.
Published: (2022-01-01)

Photodistributed telangiectasia following use of escitalopram
by: Mario Vaccaro, et al.
Published: (2016-07-01)

A comparison between two rTMS protocols as augmentation strategies in patients with treatment-resistant depression
by: L. Larini, et al.
Published: (2023-03-01)

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders
by: Stacey L. Aldrich, et al.
Published: (2019-02-01)

Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy
by: Mencacci C, et al.
Published: (2013-02-01)

Assessment of Pharmacokinetic Effects of Herbal Medicines on Escitalopram
by: Jung YS, et al.
Published: (2024-02-01)

Mydriasis caused by ESCITALOPRAM: A case report
by: N. Bouattour, et al.
Published: (2023-03-01)

Escitalopram-induced skin rash: Dermatitis medicamentosa
by: Sangha M Godi, et al.
Published: (2022-01-01)

A rare adverse drug reaction to escitalopram
by: Monika Pathania, et al.
Published: (2018-01-01)

Reversible Hemifacial Spasm after Starting Escitalopram
by: Mazen Abdulrahaman Basheikh
Published: (2020-03-01)

HPLC determination of Escitalopram in tablet dosage forms
by: Stefan Balkanski
Published: (2022-01-01)

Depression in acromegaly treated with escitalopram and cognitive therapy
by: De Sousa Avinash
Published: (2009-01-01)

Experimental Study of the Analgesic Effect of the Antidepressant Escitalopram
by: Zlatanova Hristina I., et al.
Published: (2018-09-01)

Electroacupuncture versus Escitalopram for mild to moderate Post-Stroke Depression: A randomized non-inferiority trial
by: Feixiang Ma, et al.
Published: (2024-02-01)

Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis
by: Juntao Yin, et al.
Published: (2023-11-01)

Scopolamine augmentation of a newly initiated escitalopram treatment for major depressive disorder: study protocol for a randomized controlled trial
by: Jingjing Zhou, et al.
Published: (2019-01-01)

Case report of psychosomatic illness: The management of primary hyperhidrosis with oral escitalopram
by: Amey Y Angane, et al.
Published: (2022-01-01)

Effects of escitalopram therapy on functional brain controllability in major depressive disorder
by: Fang, F, et al.
Published: (2022)

Escitalopram in the treatment of Malaysian patients with Obsessive-compulsive disorder
by: Hatim, A., et al.
Published: (2008)

Protective Effect of Escitalopram on Hepatocellular Carcinoma by Inducing Autophagy
by: Li-Jeng Chen, et al.
Published: (2022-08-01)

Unraveling the Potential of Isorhamnetin as an Adjuvant in Depression Treatment with Escitalopram
by: Omar Gammoh, et al.
Published: (2023-09-01)

Feasibility, and barriers to use escitalopram in functional gastrointestinal disorders
by: Saad S. Alkhowaiter, et al.
Published: (2023-05-01)